Schall Law Firm Investigates CVS Health/Aetna AI Denials
Analysis based on 11 articles · First reported Feb 18, 2026 · Last updated Mar 11, 2026
The investigation into CVS Health and CVS Health===Aetna for allegedly using AI to deny healthcare claims could negatively impact their stock prices and reputation within the healthcare and insurance sectors. It also highlights broader concerns about the ethical use of AI in healthcare, potentially leading to increased regulatory scrutiny across the industry.
The Schall Law Firm has announced an investigation into CVS Health and its subsidiary CVS Health===Aetna regarding alleged breach of contract and violations of state laws. The focus is on whether CVS Health/CVS Health===Aetna wrongfully denied prior authorizations for post-acute care to policyholders of CVS Health===Aetna Medicare Advantage plans, specifically through the use of an artificial intelligence program. This conduct has previously drawn scrutiny from the United States===United States Senate. The investigation covers denials from November 2019 to the present, with concerns that AI may have vetted claims before review by medical professionals, contrary to contractual obligations.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard